$1.41 Billion is the total value of Crestline Management, LP's 1 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JUNO | New | JUNO THERAPEUTICS INC | $1,414,354,000 | – | 27,084,525 | +100.0% | 100.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-07-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 98.0% |
| MICROCHIP TECHNOLOGY INC. | 20 | Q3 2023 | 1.0% |
| META PLATFORMS INC | 16 | Q3 2023 | 3.8% |
| ANALOG DEVICES INC | 16 | Q3 2023 | 1.8% |
| VOYA FINL INC | 15 | Q2 2023 | 1.3% |
| AMERICAN INTL GROUP INC | 14 | Q3 2023 | 1.6% |
| MICROSOFT CORP | 14 | Q3 2023 | 2.0% |
| GRAPHIC PACKAGING HLDG CO | 14 | Q3 2023 | 0.9% |
| JUNO THERAPEUTICS INC | 13 | Q4 2017 | 100.0% |
| ALLSTATE CORP | 13 | Q3 2023 | 1.9% |
View Crestline Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 4 | 2022-06-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Crestline Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.